Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years

[1]  M. McEntee,et al.  Are mammographic density phenotypes associated with breast cancer treatment response and clinical outcomes? A systematic review and meta-analysis. , 2019, Breast.

[2]  Michael Berks,et al.  Prediction of reader estimates of mammographic density using convolutional neural networks , 2019, Journal of medical imaging.

[3]  L. Eriksson,et al.  Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer , 2018, JNCI cancer spectrum.

[4]  Jack Cuzick,et al.  Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer , 2018, Breast Cancer Research.

[5]  S. Astley,et al.  Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction , 2018, JAMA oncology.

[6]  The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study , 2018, Breast Cancer Research.

[7]  Susan M. Astley,et al.  A comparison of five methods of measuring mammographic density: a case-control study , 2018, Breast Cancer Research.

[8]  Jingmei Li,et al.  A comprehensive tool for measuring mammographic density changes over time , 2018, Breast Cancer Research and Treatment.

[9]  C. Vachon,et al.  Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[10]  Lesley Fallowfield,et al.  Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Susan M. Astley,et al.  Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study , 2016 .

[12]  R. Hoover,et al.  Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[13]  H. Putter,et al.  Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis , 2015, Acta oncologica.

[14]  Gretchen L. Gierach,et al.  Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer. , 2015, Journal of the National Cancer Institute.

[15]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[16]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[17]  E. Lee,et al.  Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients , 2013, Breast Cancer Research and Treatment.

[18]  Kamila Czene,et al.  Change of mammographic density predicts the risk of contralateral breast cancer - a case-control study , 2013, Breast Cancer Research.

[19]  A. LaCroix,et al.  Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data , 2013, The Lancet.

[20]  Kamila Czene,et al.  Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Woo Kyung Moon,et al.  Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer , 2012, Breast Cancer Research.

[22]  K. Kerlikowske,et al.  Do fatty breasts increase or decrease breast cancer risk? , 2012, Breast Cancer Research.

[23]  R Peto,et al.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.

[24]  S. Duffy,et al.  Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study. , 2011, Journal of the National Cancer Institute.

[25]  David J. Hand,et al.  Predictive-sequential forecasting system development for cash machine stocking , 2010 .

[26]  Nico Karssemeijer,et al.  Robust breast composition measurement - Volpara™ , 2010 .

[27]  Nico Karssemeijer,et al.  Robust Breast Composition Measurement - VolparaTM , 2010, Digital Mammography / IWDM.

[28]  Susan A. Murphy,et al.  Monographs on statistics and applied probability , 1990 .

[29]  D. Altman,et al.  Calculating correlation coefficients with repeated observations: Part 2—correlation between subjects , 1995, BMJ.

[30]  D. Hand,et al.  Analysis of Repeated Measures , 1990 .

[31]  A. P. Dawid,et al.  Present position and potential developments: some personal views , 1984 .